Back

New Alzheimer’s treatments are being developed and cognitive assessments must keep pace

Read our whitepaper to learn more about monitoring cognitive impairment

 
As new Alzheimer’s disease treatments are being developed and public awareness and prevalence of the disease continue to rise, so too does the need for reliable cognitive assessment tools. To achieve an accurate diagnosis of Alzheimer disease, experts recommend these assessments in tandem with diagnostic imaging.

Philips IntelliSpace Cognition (ISC) generates a detailed cognitive profile, so clinicians have more of the data they need to identify patterns characteristic for Alzheimer’s disease versus more atypical patterns. With Philips ISC you get results that are:

  • Easy to read
  • Rapid
  • Validated

Learn more about our IntelliSpace Cognition Platform